The Harding Loevner Global Developed Markets Equity composite fell 1.0% (gross) in Q4 2024, while the MSCI World Index was ...

Market OverviewThe global Molecular Diagnostics Market is valued at USD 14.9 Billion in 2022 and is projected to reach a ...

The global Gene Editing Market was valued at $5.1 billion in 2022 and is projected to reach $16.2 billion by 2030, growing at ...

Harding Loevner Global Equity ADR composite fell 1.12% (gross) in Q4 2024, compared with the 0.89% decline of the MSCI ACWI ...

Of all the risks associated with pharmaceuticals and medical devices, controlling contamination is one of the most important and difficult challenges. Relational risk analysis (ReRA) can help.